The Next Generation of Energy: The Importance of Power Quality

 

Where did the understanding that power quality was an issue people needed to pay attention to begin? Joe Piccirilli, CEO of Rosewater Energy Group, said it was mission-critical environments where power quality problems first became an issue. Piccirilli and Mario Bottero, COO of Rosewater Energy Group, dove into the topic of power quality, focusing on why it’s so essential in today’s world of multiple devices and IoT.

Why did this particular issue first gain notoriety in mission-critical environments? Piccirilli said it was due to these facilities’ abundance of high calibrated, highly sensitive equipment.

“Equipment that’s calibrated on power quality and is sensitive to voltage fluctuation, in those kinds of facilities, had dire consequences,” Piccirilli said. “The equipment went down, and it took forever to recalibrate. And, as we became more technical and the equipment used in these facilities had more and more microprocessors, power quality became incredibly important.”

In short order, the same type of advanced technologies driving mission-critical environments became the norm for healthcare facilities and, now, everyday use items.

“Today, in modern residences, we have highly sophisticated, highly calibrated control systems that are extremely sensitive,” Piccirilli said. “In the best case, these microprocessors lose longevity. In the worst case, they stop functioning.”

So, if the power quality is a problem, what’s the solution? UPS power backups can be a remedy, but even here, not all backup devices are the same.

“The difficulty for the public at large is how to tell whether a device is improving power quality,” Piccirilli said. “One of the things that is incredibly important is if there is a transfer time.”

Transfer time is the amount of time it takes for the backup battery power to kick in. Even a tiny amount can do long-term harm to devices and equipment and eliminate the power quality benefit. In a Rosewater device, transfer time is zero.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More